Niceritrol
Niceritrol (pronunciation: ni-ser-i-trol) is a vasodilator and nicotinic acid derivative used in the treatment of hyperlipidemia. It is also known as Pafuramid and Paprodil.
Etymology
The term Niceritrol is derived from the words nicotinic acid and vasodilator. The nicer part of the word comes from nicotinic acid, a type of B vitamin that is used to lower cholesterol. The trol part of the word comes from vasodilator, a type of medication that dilates (widens) blood vessels.
Pharmacology
Niceritrol is a nicotinic acid derivative that acts as a vasodilator. It works by reducing the production of low-density lipoprotein (LDL) cholesterol and increasing the production of high-density lipoprotein (HDL) cholesterol. This helps to reduce the risk of atherosclerosis, a condition in which fatty deposits build up in the arteries.
Usage
Niceritrol is used in the treatment of hyperlipidemia, a condition characterized by abnormally elevated levels of any or all lipids or lipoproteins in the blood. It is also used to treat coronary artery disease, a type of heart disease that occurs when the arteries that supply blood to the heart muscle become hardened and narrowed.
Side Effects
Common side effects of Niceritrol include flushing, itching, and gastrointestinal disturbances. Less common side effects include dizziness, headache, and rash.
Related Terms
- Vasodilator
- Nicotinic acid
- Hyperlipidemia
- Coronary artery disease
- Atherosclerosis
- Low-density lipoprotein
- High-density lipoprotein
External links
- Medical encyclopedia article on Niceritrol
- Wikipedia's article - Niceritrol
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski